Abstract:Nerve stimulation‐evoked contraction of muscles from mild MuSK myasthenia gravis mice (injected with low doses patient IgG4) appeared partly insensitive to μ‐Conotoxin‐GIIIB. This blocker of NaV1.4 voltage‐gated sodium channels normally completely eliminates muscle contraction. We studied neuromuscular transmission and possible compensatory expression of NaV1.5 (cardiac‐type) channels but showed this was not the case. Which other Na channel types or related factors are involved remains to be seen. Muscle‐specific kinase myasthenia gravis (MuSK MG) is caused by autoantibodies against MuSK in the neuromuscular junction (NMJ). MuSK MG patients have fluctuating, fatigable skeletal muscle weakness, in particular of bulbar muscles. Severity differs greatly between patients, in spite of comparable autoantibody levels. One explanation for inter‐patient and inter‐muscle variability in sensitivity might be variations in compensatory muscle responses. Previously, we developed a passive transfer mouse model for MuSK MG. In preliminary ex vivo experiments, we observed that muscle contraction of some mice, in particular those with milder myasthenia, had become partially insensitive to inhibition by μ‐Conotoxin‐GIIIB, a blocker of skeletal muscle NaV1.4 voltage‐gated sodium channels. We hypothesised that changes in NaV channel expression profile, possibly co‐expression of (μ‐Conotoxin‐GIIIB insensitive) NaV1.5 type channels, might lower the muscle fibre's firing threshold and facilitate neuromuscular synaptic transmission. To test this hypothesis, we here performed passive transfer in immuno‐compromised mice, using 'high', 'intermediate' and 'low' dosing regimens of purified MuSK MG patient IgG4. We compared myasthenia levels, μ‐Conotoxin‐GIIIB resistance and muscle fibre action potential characteristics and firing thresholds. High‐ and intermediate‐dosed mice showed clear, progressive myasthenia, not seen in low‐dosed animals. However, diaphragm NMJ electrophysiology demonstrated almost equal myasthenic severities amongst all regimens. Nonetheless, low‐dosed mouse diaphragms showed a much higher degree of μ‐Conotoxin‐GIIIB resistance. This was not explained by upregulation of Scn5a (the NaV1.5 gene), lowered muscle fibre firing thresholds or histologically detectable upregulated NaV1.5 channels. It remains to be established which factors are responsible for the observed μ‐Conotoxin‐GIIIB insensitivity and whether the NaV repertoire change is compensatory beneficial or a bystander effect.

MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity.

Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice.

The MuSK-BMP pathway regulates synaptic Nav1.4 localization and muscle excitability

Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor clustering.

The Ig1/2 domain of MuSK binds to muscle surface and is involved in acetylcholine receptor clustering.

Differential Regulation of AChR Clustering in the Polar and Equatorial Region of Murine Muscle Spindles.

IgG1-3 MuSK Antibodies Inhibit AChR Cluster Formation, Restored by SHP2 Inhibitor, Despite Normal MuSK, DOK7, or AChR Subunit Phosphorylation

Change of voltage‐gated sodium channel repertoire in skeletal muscle of a MuSK myasthenia gravis mouse model

From phosphorylation to phenotype - Recent key findings on kinase regulation, downstream signaling and disease surrounding the receptor tyrosine kinase MuSK

Agrin/Lrp4 signal constrains MuSK-dependent neuromuscular synapse development in appendicular muscle

Muscle-Specific Receptor Tyrosine Kinase Endocytosis in Acetylcholine Receptor Clustering in Response to Agrin

Muscle-wide Secretion of a Miniaturized Form of Neural Agrin Rescues Focal Neuromuscular Innervation in Agrin Mutant Mice.

Single-nuclei sequencing of skeletal muscle reveals subsynaptic-specific transcripts involved in neuromuscular junction maintenance

Endosomal trafficking of the receptor tyrosine kinase MuSK proceeds via clathrin-dependent pathways, Arf6 and actin

Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA)

The Merg1a Channel Modulates Skeletal Muscle Murf1, but Not Mafbx, Expression

Neuromuscular synapse formation in mice lacking motor neuron- and skeletal muscle-derived Neuregulin-1

Regulation of Ach Receptor Clustering by the Tyrosine Phosphatase Shp2

The Role of Nerve- Versus Muscle-Derived Factors in Mammalian Neuromuscular Junction Formation

Src-Family Kinases Stabilize the Neuromuscular Synapse in Vivo Via Protein Interactions, Phosphorylation, and Cytoskeletal Linkage of Acetylcholine Receptors

MuSK myasthenia gravis monoclonal antibodies